A new cancer vaccine is being created to analyse how pre-cancerous cells develop to target the disease before it takes hold.
Some oncologists suggest that, for certain early cancers not at risk of spreading, the term “cancer” should be avoided.
An enhanced model that integrates non-AJCC clinical features provides clinicians with a more accurate tool for identifying high-risk patients with MCC.